Hasan Uludağ

11.5k total citations · 2 hit papers
237 papers, 9.5k citations indexed

About

Hasan Uludağ is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Hasan Uludağ has authored 237 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Molecular Biology, 56 papers in Biomedical Engineering and 45 papers in Oncology. Recurrent topics in Hasan Uludağ's work include RNA Interference and Gene Delivery (132 papers), Advanced biosensing and bioanalysis techniques (77 papers) and Bone Tissue Engineering Materials (37 papers). Hasan Uludağ is often cited by papers focused on RNA Interference and Gene Delivery (132 papers), Advanced biosensing and bioanalysis techniques (77 papers) and Bone Tissue Engineering Materials (37 papers). Hasan Uludağ collaborates with scholars based in Canada, United States and Thailand. Hasan Uludağ's co-authors include Afsaneh Lavasanifar, Cezary Kucharski, Charlie Yu Ming Hsu, Paul de Vos, Patrick A. Tresco, Tian Tang, Eleni K. Tsekoura, Sufeng Zhang, Xiao-Bing Xiong and John M. Wozney and has published in prestigious journals such as Chemical Society Reviews, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Hasan Uludağ

231 papers receiving 9.3k citations

Hit Papers

Current state of fabrication technologies and materials f... 2018 2026 2020 2023 2018 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Current state of fabrication technologies and materials for bone tissue engineering
    2018 460 citations Hasan Uludağ et al. Acta Biomaterialia profile →
  2. Nanofibers as new-generation materials: From spinning and nano-spinning fabrication techniques to emerging applications
    2019 348 citations Hasan Uludağ et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hasan Uludağ Canada 53 4.4k 3.3k 2.3k 1.4k 1.1k 237 9.5k
Lianfu Deng China 58 2.8k 0.6× 4.5k 1.4× 3.1k 1.4× 2.0k 1.5× 705 0.7× 217 11.3k
Marcel Karperien Netherlands 64 5.9k 1.3× 3.5k 1.1× 2.5k 1.1× 2.3k 1.7× 2.1k 2.0× 309 15.4k
William L. Murphy United States 57 3.2k 0.7× 6.5k 2.0× 3.3k 1.4× 2.4k 1.7× 735 0.7× 226 11.5k
Chia Soo United States 53 2.9k 0.7× 2.0k 0.6× 1.1k 0.5× 1.9k 1.4× 660 0.6× 151 8.3k
James T. Triffitt United Kingdom 47 2.3k 0.5× 2.4k 0.7× 1.2k 0.6× 1.6k 1.1× 1.3k 1.2× 151 8.2k
Kang Ting United States 51 3.0k 0.7× 2.0k 0.6× 1.0k 0.5× 1.7k 1.3× 551 0.5× 160 8.1k
Jiacan Su China 58 3.9k 0.9× 4.3k 1.3× 2.0k 0.9× 1.7k 1.2× 952 0.9× 333 11.2k
Andrew C.W. Zannettino Australia 61 5.1k 1.2× 1.6k 0.5× 1.5k 0.7× 2.5k 1.8× 2.9k 2.6× 249 13.3k
Sarah C. Heilshorn United States 66 3.6k 0.8× 6.7k 2.0× 3.9k 1.7× 2.1k 1.5× 1.3k 1.2× 187 14.1k
Marja J.A. van Luyn Netherlands 53 2.1k 0.5× 2.3k 0.7× 3.7k 1.6× 2.3k 1.7× 456 0.4× 146 8.8k

Countries citing papers authored by Hasan Uludağ

Since Specialization
Citations

This map shows the geographic impact of Hasan Uludağ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Uludağ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Uludağ more than expected).

Fields of papers citing papers by Hasan Uludağ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasan Uludağ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Uludağ. The network helps show where Hasan Uludağ may publish in the future.

Co-authorship network of co-authors of Hasan Uludağ

This figure shows the co-authorship network connecting the top 25 collaborators of Hasan Uludağ. A scholar is included among the top collaborators of Hasan Uludağ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasan Uludağ. Hasan Uludağ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasrullah, Mohammad, K Bahadur, Cezary Kucharski, et al.. (2025). Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic Delivery. Advanced Healthcare Materials. 14(27). e02019–e02019.
2.
Morales, Luis Carlos, Mohammad Nasrullah, Cezary Kucharski, et al.. (2024). Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models. Journal of Controlled Release. 367. 821–836. 12 indexed citations
3.
4.
Morales, Luis Carlos, et al.. (2024). Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems. Molecular Pharmaceutics. 21(3). 1436–1449. 4 indexed citations
5.
Nasrullah, Mohammad, K Bahadur, Cezary Kucharski, et al.. (2024). Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia. ACS Pharmacology & Translational Science. 7(9). 2840–2855. 3 indexed citations
6.
Brandwein, Joseph, et al.. (2023). Exploring the Potential of siRNA Delivery in Acute Myeloid Leukemia for Therapeutic Silencing. Nanomaterials. 13(24). 3167–3167. 1 indexed citations
7.
Thapa, Bindu, K Bahadur, Xin Liu, et al.. (2022). TRAIL Therapy for Breast Cancer Treatment by Employing Lipopolymer mRNA Delivery. 1(1). 101–112. 3 indexed citations
8.
Ghaffari, Maryam, et al.. (2021). COVID-19: insights into virus–receptor interactions. Molecular Biomedicine. 2(1). 10–10. 6 indexed citations
9.
10.
Mohseni, Mahsa, Cezary Kucharski, Remant Bahadur K.C., et al.. (2021). Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL). PLoS ONE. 16(6). e0251719–e0251719. 9 indexed citations
11.
Uludağ, Hasan, et al.. (2020). Prospects for RNAi Therapy of COVID-19. Frontiers in Bioengineering and Biotechnology. 8. 916–916. 64 indexed citations
12.
Thapa, Bindu, K Bahadur, Mary Hitt, et al.. (2019). Breathing New Life into TRAIL for Breast Cancer Therapy: Co-Delivery of pTRAIL and Complementary siRNAs Using Lipopolymers. Human Gene Therapy. 30(12). 1531–1546. 14 indexed citations
13.
Bahadur, K, et al.. (2018). BCR-Abl Silencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy. Stem Cells and Development. 28(11). 734–744. 19 indexed citations
14.
Bilecen, Deniz, Hasan Uludağ, & Vasıf Hasırcı. (2018). Development of PEI- RANK siRNA Complex Loaded PLGA Nanocapsules for the Treatment of Osteoporosis. Tissue Engineering Part A. 25(1-2). 34–43. 31 indexed citations
15.
K.C., Remant Bahadur, et al.. (2017). Nucleic acid combinations: A new frontier for cancer treatment. Journal of Controlled Release. 256. 153–169. 25 indexed citations
16.
Uludağ, Hasan, et al.. (2016). Current attempts to implement siRNA-based RNAi in leukemia models. Drug Discovery Today. 21(9). 1412–1420. 12 indexed citations
17.
Gül-Uludağ, Hilal, Cezary Kucharski, Leah A. Marquez‐Curtis, et al.. (2014). Polymeric nanoparticle-mediated silencing of CD44 receptor in CD34+ acute myeloid leukemia cells. Leukemia Research. 38(11). 1299–1308. 44 indexed citations
18.
Mahdipoor, Parvin, et al.. (2013). Pharmacokinetics and transgene expression of implanted polyethylenimine-based pDNA complexes. Biomaterials Science. 2(6). 833–842. 6 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianfu Deng Breakdown of academic impact, for papers by Marcel Karperien Breakdown of academic impact, for papers by William L. Murphy Breakdown of academic impact, for papers by Chia Soo Breakdown of academic impact, for papers by James T. Triffitt Breakdown of academic impact, for papers by Kang Ting Breakdown of academic impact, for papers by Jiacan Su Breakdown of academic impact, for papers by Andrew C.W. Zannettino Breakdown of academic impact, for papers by Sarah C. Heilshorn Breakdown of academic impact, for papers by Marja J.A. van Luyn
Rankless by CCL
2026